FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN: Safety Overview
| Metric | FOSAPREPITANT DIMEGLUMINE | FOSFOMYCIN |
|---|---|---|
| Total FAERS Reports | 888 | 828 |
| Deaths Reported | 118 | 128 |
| Death Rate | 13.3% | 15.5% |
| Hospitalizations | 364 | 407 |
| Average Patient Age | 57.0 yrs | 55.3 yrs |
| % Female Patients | 50.1% | 57.3% |
| FDA Approval Date | Aug 20, 2020 | Oct 22, 2025 |
| Manufacturer | Dr. Reddy's Laboratories Inc., | Meitheal Pharmaceuticals Inc. |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Discontinued | Prescription |